Article

Clinical characteristics and association with immunotherapy outcomes in SMARCA4-deficient NSCLC

2024-06-13

Abstract excerpt

<title>Abstract</title> <p>Introduction: SMARCA4, also known as transcription activator, is an ATP-dependent catalytic subunit of SWI/SNF chromatin-remodeling complexes that participates in the regulation of chromatin structure and gene expression by supplying energy. <italic>SMARCA4</italic>-deficient lung cancer has been recognized as a distinct subtype based on subtle differences in its clinical, morphological...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 057d1bcd-2d5b-5572-a0fe-b9eccd96f833
DOI: 10.21203/rs.3.rs-4431729/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinical characteristics and association with immunotherapy outcomes in SMARCA4-deficient NSCLCDOI 10.21203/rs.3.rs-4431729/v1Read

[Research Progress on SMARCA4 Mutation Non-small Cell Lung Cancer].Semantic proximity Read

SMARCA4: Current status and future perspectives in non-small-cell lung cancerSemantic proximity Read

Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods.Semantic proximity Read

A Pan-Cancer Analysis of SMARCA4 Alterations in Human Cancers.Semantic proximity Read

Clinicopathological characteristics and treatment outcomes of advanced SMARCA4-deficient thoracic tumors.Semantic proximity Read

Clinical features and prognostic biomarkers in patients with SMARCA4-mutated non-small cell lung cancerSemantic proximity Read

Clinical features and prognostic biomarkers of patients with the rare SMACRA4 gene mutation in non-small cell lung cancerSemantic proximity Read

A Critical Review of the Impact of SMARCA4 Mutations on Survival Outcomes in Non-Small Cell Lung CancerSemantic proximity Read

Perspectives and Issues in the Assessment of SMARCA4 Deficiency in the Management of Lung Cancer Patients.Semantic proximity Read

<i>SMARCA4</i> Mutations in <i>KRAS</i>-mutant Lung Adenocarcinoma: A Multi-cohort AnalysisSemantic proximity Read

Clinicopathological characteristics and therapeutic outcomes in patients with non-small cell lung cancer harboring SMARCA4 mutations.Semantic proximity Read

The role of SMARCA4 in lung cancerSemantic proximity Read